A detailed history of Massachusetts Financial Services CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 9,330,779 shares of ABBV stock, worth $1.69 Billion. This represents 0.58% of its overall portfolio holdings.

Number of Shares
9,330,779
Previous 8,956,977 4.17%
Holding current value
$1.69 Billion
Previous $1.54 Billion 19.94%
% of portfolio
0.58%
Previous 0.49%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $61.2 Million - $74.5 Million
373,802 Added 4.17%
9,330,779 $1.84 Billion
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $42.3 Million - $49.4 Million
273,429 Added 3.15%
8,956,977 $1.54 Billion
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $41.7 Million - $47.5 Million
260,935 Added 3.1%
8,683,548 $1.58 Billion
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $329 Million - $370 Million
2,390,239 Added 39.62%
8,422,613 $1.31 Billion
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $803 Million - $930 Million
6,012,281 Added 29922.27%
6,032,374 $899 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $1.11 Million - $1.38 Million
-8,353 Reduced 29.36%
20,093 $2.71 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $1.69 Million - $1.95 Million
11,681 Added 69.67%
28,446 $4.53 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $42,046 - $50,424
304 Added 1.85%
16,765 $2.71 Million
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $1.63 Million - $1.87 Million
-12,130 Reduced 42.43%
16,461 $2.21 Million
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $3.93 Million - $5 Million
28,591 New
28,591 $4.38 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $2.78 Million - $3.45 Million
-21,073 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $2.22 Million - $2.8 Million
-20,620 Reduced 49.46%
21,073 $2.85 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $80,651 - $91,551
758 Added 1.85%
41,693 $4.5 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $162,444 - $180,972
-1,544 Reduced 3.63%
40,935 $4.61 Million
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $1.08 Million - $1.18 Million
-10,512 Reduced 19.84%
42,479 $4.6 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $14.8 Million - $19.9 Million
-183,492 Reduced 77.59%
52,991 $5.68 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $9.02 Million - $10.6 Million
-105,008 Reduced 30.75%
236,483 $20.7 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $4.43 Million - $5.92 Million
60,318 Added 21.45%
341,491 $33.5 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $5.65 Million - $8.57 Million
87,593 Added 45.25%
281,173 $21.4 Million
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $2.83 Million - $3.54 Million
39,269 Added 25.45%
193,580 $17.1 Million
Q3 2019

Nov 05, 2019

BUY
$62.98 - $75.72 $9.72 Million - $11.7 Million
154,311 New
154,311 $11.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.